Non-coding RNAs, another side of immune regulation during triple-negative breast cancer

Pathol Res Pract. 2022 Nov:239:154132. doi: 10.1016/j.prp.2022.154132. Epub 2022 Sep 16.

Abstract

Triple-negative breast cancer (TNBC) is considered about 12-24 % of all breast cancer cases. Patients experience poor overall survival, high recurrence rate, and distant metastasis compared to other breast cancer subtypes. Numerous studies have highlighted the crucial roles of non-coding RNAs (ncRNAs) in carcinogenesis and proliferation, migration, and metastasis of tumor cells in TNBC. Recent research has demonstrated that long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) play a role in the regulation of the immune system by affecting the tumor microenvironment, the epithelial-mesenchymal transition, the regulation of dendritic cells and myeloid-derived stem cells, and T and B cell activation and differentiation. Immune-related miRNAs and lncRNAs, which have been established as predictive markers for various cancers, are strongly linked to immune cell infiltration and could be a viable therapeutic target for TNBC. In the current review, we discuss the recent updates of ncRNAs, including miRNAs and lncRNAs in TNBC, including their biogenesis, target genes, and biological function of their targets, which are mostly involved in the immune response.

Keywords: Immune response; Long non-coding RNA; MicroRNA; Non-coding RNA; Triple-negative breast cancer.

Publication types

  • Review

MeSH terms

  • Carcinogenesis / genetics
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • MicroRNAs* / genetics
  • RNA, Long Noncoding* / genetics
  • RNA, Untranslated
  • Triple Negative Breast Neoplasms* / pathology
  • Tumor Microenvironment

Substances

  • RNA, Long Noncoding
  • MicroRNAs
  • RNA, Untranslated